-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Maintains Buy on ORIC Pharmaceuticals, Raises Price Target to $17

Benzinga·02/24/2026 18:13:58
Listen to the news
Citigroup analyst Yigal Nochomovitz maintains ORIC Pharmaceuticals (NASDAQ:ORIC) with a Buy and raises the price target from $16 to $17.